Jones Financial Companies
TXG icon

Jones Financial Companies’s 10x Genomics TXG Stock Holding History

Jones Financial Companies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Buy
21,248
+18,429
+654% +$483K ﹤0.01% 2019
2026
Q1 		$54.9K Buy
2,819
+1,547
+122% +$30.9K ﹤0.01% 2923
2025
Q4 		$20.7K Sell
1,272
-380
-23% -$5.74K ﹤0.01% 2913
2025
Q3 		$19.4K Buy
1,652
+886
+116% +$11.6K ﹤0.01% 2819
2025
Q2 		$8.98K Sell
766
-1,171
-60% -$10.7K ﹤0.01% 2910
2025
Q1 		$17.7K Buy
1,937
+462
+31% +$5.82K ﹤0.01% 2481
2024
Q4 		$21.2K Buy
1,475
+431
+41% +$6.8K ﹤0.01% 2234
2024
Q3 		$23.7K Buy
1,044
+917
+722% +$19K ﹤0.01% 1896
2024
Q2 		$2.47K Buy
+127
New +$3.33K ﹤0.01% 2115

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's TXG Position: Q2 2026 in Review

Jones Financial Companies increased its 10x Genomics (TXG) stake by 654% in Q2 2026, buying an estimated $483K and bringing the position to 21,248 shares worth $781K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

Jones Financial Companies first reported a position in TXG in Q2 2024 and has held it in 9 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Jones Financial Companies held 21,248 shares of 10x Genomics worth $781K as of Q2 2026.
  • Jones Financial Companies bought 18,429 10x Genomics shares in Q2 2026, an estimated $483K.
  • 10x Genomics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2019 holding.
  • Jones Financial Companies first reported a position in 10x Genomics in Q2 2024 and has held it in 9 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.